26 results
6-K
EX-99.1
IMRN
Immuron Limited
23 Apr 24
Report of Foreign Private Issuer
6:06am
ethics approval for Toxicology study – November 2022 Immuron sponsored Toxicology study completed - December 2022 Phase 2 CHIM completion of inpatient
6-K
EX-99.1
IMRN
Immuron Limited
28 Feb 24
Results for announcement to the market
8:08am
a GLP compliant toxicity study in rodents. The study protocol has been submitted and approved by the Animal Ethics Committee and the study is planned … of the Corporations Act 2001 and the ethical requirements of the Accounting Professional and Ethical Standards Board’s APES 110 Code of Ethics for Professional
6-K
EX-99.1
IMRN
Immuron Limited
22 Dec 23
Immuron Clinical Trials Update
7:21am
by the Animal Ethics Committee and the study is planned to commence in Q1 2024. The company is working towards submitting a Pre-IND information package
6-K
EX-99.1
IMRN
Immuron Limited
3 Oct 23
Report of Foreign Private Issuer
9:31pm
Hold on Campylobacter ETEC – 8 May 2023 Anticipated Institutional Review Board (ethics) approval – December 2023 Market Phase III Phase II Phase I
6-K
EX-99.1
IMRN
Immuron Limited
28 Sep 23
Report of Foreign Private Issuer
8:43am
Financial Reporting
ITEM 16.
RESERVED
ITEM 16A.
AUDIT COMMITTEE FINANCIAL EXPERT
ITEM 16B.
CODE OF ETHICS
ITEM 16C.
PRINCIPAL ACCOUNTANT FEES … , including, but not limited to:
government or regulatory delays, including delays in obtaining approvals from applicable hospital ethics committees
6-K
EX-99.2
55qic
28 Sep 23
Report of Foreign Private Issuer
8:43am
6-K
EX-99.1
qud8 fsjb
11 Sep 23
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
6:10am
6-K
EX-99.1
k5gn36zx
24 Jul 23
Immuron CEO, Steven Lydeamore to present at Bioshares
6:04am
6-K
EX-99.1
3jzrw7n6 5i2ippl
7 Jun 23
Immuron CEO, Steven Lydeamore presents at LD Micro
8:00am
6-K
EX-99.1
jzpt25
30 May 23
Report of Foreign Private Issuer
8:00am
6-K
EX-99.1
t82pkq
8 May 23
Report of Foreign Private Issuer
6:19am
6-K
EX-99.2
nk2q8tfr4h874r0 lwj
9 May 22
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
bsj3t9u
25 Feb 22
Results for announcement to the market
7:37am
6-K
EX-99.2
hsva6 a8bzs
30 Sep 21
Annual report - 30 June 2021
11:42am
6-K
EX-99.1
uajcsxwiqaym6
30 Sep 21
Annual report - 30 June 2021
11:42am
6-K
EX-99.1
vm6f0i6
25 Feb 21
Report of Foreign Private Issuer
7:57am